Merck KGaA
MKGAF
$142.89
-$0.11-0.08%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 5.69% | 4.22% | 3.43% | 2.26% | 1.31% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 5.69% | 4.22% | 3.43% | 2.26% | 1.31% |
| Cost of Revenue | 6.90% | 5.04% | 3.21% | 1.63% | -1.51% |
| Gross Profit | 4.86% | 3.65% | 3.58% | 2.72% | 3.34% |
| SG&A Expenses | 9.73% | 7.14% | 7.21% | 4.79% | 3.14% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -139.73% | -78.88% | -123.98% | -81.04% | -16.71% |
| Total Operating Expenses | 7.08% | 5.22% | -1.06% | -2.04% | -1.27% |
| Operating Income | 0.12% | 0.18% | 24.59% | 23.20% | 13.16% |
| Income Before Tax | -3.71% | -2.73% | 12.73% | 12.03% | 5.45% |
| Income Tax Expenses | -5.63% | -4.25% | 16.24% | 21.64% | 19.19% |
| Earnings from Continuing Operations | -3.19% | -2.32% | 11.86% | 9.73% | 2.25% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -115.01% | 25.45% | 46.57% | -66.16% | 45.64% |
| Net Income | -3.47% | -2.24% | 12.04% | 9.58% | 2.46% |
| EBIT | 0.12% | 0.18% | 24.59% | 23.20% | 13.16% |
| EBITDA | 7.49% | 6.04% | 12.84% | 11.28% | 4.61% |
| EPS Basic | -3.51% | -2.44% | 11.82% | 9.41% | 2.41% |
| Normalized Basic EPS | -0.99% | 0.07% | 19.96% | 19.23% | 13.58% |
| EPS Diluted | -3.51% | -2.44% | 11.91% | 9.50% | 2.49% |
| Normalized Diluted EPS | -0.99% | 0.07% | 19.96% | 19.23% | 13.58% |
| Average Basic Shares Outstanding | 0.04% | 0.19% | 0.19% | 0.15% | 0.03% |
| Average Diluted Shares Outstanding | 0.04% | 0.19% | 0.19% | 0.15% | 0.03% |
| Dividend Per Share | 9.21% | 9.21% | -0.99% | -0.99% | -0.99% |
| Payout Ratio | 0.08% | 0.08% | -0.05% | -0.03% | -0.11% |